NTRA · XBRL financial data

Natera financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (NTRA's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	268	311*	368	413	440	476*	502	547	592	665*	697	753
Research and development	77	83*	89	89	97	129*	129	146	173	175*	211	228
Selling, general and administrative	155	161*	194	198	214	235*	267	311	309	291*	328	327
Operating income (loss)	(111)	(85)*	(74)	(44)	(39)	(65)*	(79)	(110)	(98)	(23)*	(94)	(76)
Interest expense	3	3*	3	3	3	1*	1	1	1	1*	1	1
Other income (expense)	—	—	—	—	—	—	13	11	—	—	10	9
Income tax expense (benefit)	0	0*	0	1	1	(1)*	0	0	0	(61)*	0	(0)
Net income (loss)	(109)	(78)*	(68)	(37)	(32)	(54)*	(67)	(101)	(88)	47*	(85)	(67)
Earnings per share, basic USD per share	(0.95)	(0.65)*	(0.56)	(0.30)	(0.26)	(0.41)*	(0.50)	(0.74)	(0.64)	0.34*	(0.60)	(0.47)
Earnings per share, diluted USD per share	(0.95)	(0.65)*	(0.56)	(0.30)	(0.26)	(0.41)*	(0.50)	(0.74)	(0.64)	0.34*	(0.60)	(0.47)
Weighted average shares, basic millions of shares	115	119*	121	123	124	131*	135	136	137	139*	142	143
Weighted average shares, diluted millions of shares	115	119*	121	123	124	131*	135	136	137	139*	142	143

Fiscal quarters (NTRA's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	669	642	814	797	893	946	974	1,000	1,041	1,076	1,088	1,092
Marketable securities	268	237	69	90	29	23	18	16	1	—	—	—
Accounts receivable	255	278	289	336	307	314	318	309	286	297	418	422
Inventory	42	41	43	41	49	45	50	54	65	68	71	80
Prepaid and other current assets	33	61	47	38	45	49	56	52	54	56	76	65
Total current assets	1,267	1,259	1,261	1,302	1,323	1,376	1,416	1,432	1,447	1,497	1,652	1,659
Property and equipment, net	105	111	126	133	142	162	180	189	206	241	269	318
Right-of-use asset	58	57	55	53	88	86	95	95	97	109	134	130
Goodwill	—	—	—	—	—	—	—	—	—	141	141	141
Total assets	1,447	1,442	1,468	1,517	1,591	1,661	1,732	1,757	1,821	2,398	2,614	2,657
Accounts payable	21	15	26	33	28	35	39	37	46	33	62	75
Total current liabilities	290	307	306	315	301	344	366	385	442	441	558	553
Lease liability, non-current	68	67	64	61	99	97	103	103	104	118	145	143
Total liabilities	662	676	674	680	712	465	493	511	569	686	840	836
Accumulated deficit	(2,299)	(2,377)	(2,445)	(2,482)	(2,514)	(2,568)	(2,635)	(2,736)	(2,823)	(2,776)	(2,861)	(2,928)
Total stockholders' equity	785	765	794	837	879	1,195	1,240	1,246	1,252	1,712	1,774	1,821
Total liabilities and equity	1,447	1,442	1,468	1,517	1,591	1,661	1,732	1,757	1,821	2,398	2,614	2,657
Common shares outstanding (cover page) millions of shares	120	121	123	124	132	135	137	137	138	142	143	144

Fiscal quarters (NTRA's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(109)	(78)*	(68)	(37)	(32)	(54)*	(67)	(101)	(88)	47*	(85)	(67)
Stock-based compensation	58*	49*	64	67*	71*	72*	78	93*	91*	93*	95	103*
Depreciation and amortization	7*	7*	7	8*	8*	8*	9	10*	10*	12*	15	15*
Net cash from operating activities	(30)*	(58)*	27	4*	52*	53*	44	38*	59*	74*	40	55*
Purchases of property and equipment	9*	10*	20	12*	16*	18*	22	26*	22*	36*	22	63*
Net cash from investing activities	81*	25*	138	(32)*	43*	(11)*	(17)	(24)*	(20)*	(72)*	(32)	(63)*
Net cash from financing activities	236*	7*	6	11*	2*	11*	1	13*	2*	32*	4	12*
Net change in cash	—	—	—	—	—	—	28	26*	—	—	12	4*

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Natera	1,092	753	55*	144.1M	—	Q2 FY26 10-QJun 30, 2026
Labcorp Holdings	262	3,810	564*	81.2M	—	Q3 FY26 10-QSep 30, 2026
Quest Diagnostics	797	3,097	611*	110.0M	—	Q3 FY26 10-QSep 30, 2026
Exact Sciences	956	878*	152*	190.9M	—	Q4 FY25 10-KDec 31, 2025
Lumexa Imaging Holdings	70	264	33*	96.1M	—	Q2 FY26 10-QJun 30, 2026
Guardant Health	1,053	335	(58)*	134.2M	18.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.